Pancreatic Cancer Research

ResearcherYanbian UniversityNo recent work listed

Meiying Ji

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5051716236. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

  1. Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer. Co-author PMID 30662800↗
  2. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. Co-author DOI 10.3892/ol.2017.5821↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liyan Chen · 2 shared papers, 2017–2018 · strength 0.19
  2. Zhenhua Lin · 1 shared paper, 2018 · strength 0.12
  3. Aihua Jin · 1 shared paper, 2017 · strength 0.08
  4. Yang Yang · 1 shared paper, 2017 · strength 0.08
  5. Xuelian Cui · 1 shared paper, 2017 · strength 0.08
  6. Jie Lena Sun · 1 shared paper, 2017 · strength 0.08
  7. Zhenhua Lin · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.